Pimobendan is a heart medication used to treat dogs with congestive heart failure (CHF) usually caused by dilated cardiomyopathy or valvular insufficiency
Anant Labs manufacture and furnish high quality Pimobendan impurities for global markets. Our Pimobendan EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
rac Pimobendanpimobendan74150-27-9pimobendaneAcardidl-PimobendanVetmedinPimobendanumUD-CG-115BSRacemic pimobendanUD-CG-115UDCG-11534AP3BBP9TDTXSID8048280CHEBI:32003FORTEKOR PLUS COMPONENT PIMOBENDAN3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-4,5-dihydropyridazin-3(2H)-oneUD-CG115Pimobendan,USPVetmedin SolutionPimobendan EP56-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-oneVetmedin-CA1RefChem:55860SolutitionKits PimobendanDTXCID90282554,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazole-5-yl)-5-methyl-3(2H)-pyridazinoned-PimobendanPimobendan, (-)-(-)-Pimobendanl-Pimobendan(+)-Pimobendan118428-37-86-(2-(4-METHOXYPHENYL)-1H-BENZO[D]IMIDAZOL-5-YL)-5-METHYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONEPimobendan, (+)-Pimobendan (Vetmedin)MFCD007616483-[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one118428-38-9BRN 4207330CHEMBL24646613JXV89SU9HTU209Z0N3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, (+)-3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, (-)-Racemic pinobendanUD-CG 115UD-CG 115 BSPimobendan [INN-Spanish]Pimobendane [INN-French]Pimobendanum [INN-Latin](+)-UD-CG 115BS(-)-UD-CG 115BSNCGC00274063-01UNII-34AP3BBP9TUNII-613JXV89SUUNII-9HTU209Z0NPimobendamPimobendan [USAN:INN:BAN]Pimobendan?4,5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-3(2H)-pyridazinonePimobendan CRSGLBJJMFZWDBELO-UHFFFAOYSA-NAcardi (TN)Pimobendan (Standard)PIMOBENDAN [MI]PIMOBENDAN [INN]PIMOBENDAN [JAN]PIMOBENDAN [USAN]PIMOBENDAN [MART.](+)-4,5-Dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone(-)-4,5-Dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone6-(2-(4-Methoxyphenyl)-4,5-dihydro-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinonePIMOBENDAN [USP-RS]PIMOBENDAN [WHO-DD]SCHEMBL27623MLS006010188Pimobendan (JAN/USAN/INN)orb1307669orb1695666SCHEMBL1649737PIMOBENDAN [GREEN BOOK]PIMOBENDAN [EP IMPURITY]Pimobendan, >=98% (HPLC)SCHEMBL29386190HY-B0204RGLXC-07557HMS3655I03HMS3884C21HMS5079O14KUC109647NPIMOBENDAN [USP MONOGRAPH]HY-B0204MSK14881AC-689BDBM50282617s1550AKOS015851937AKOS015967705CCG-267853DB11450EBC-130025FP38260KS-1280KSC-210-009PIMOBENDAN [EMA EPAR VETERINARY]Pimobendan 100 |Ig/mL in AcetonitrileNCGC00274063-04NCGC00274063-05118428-36-7Pimobendan 100 microg/mL in AcetonitrileSMR002530068SY122254DB-219709P2779Pimobendan for veterinary use [ep monograph]SW219717-1D01133SBI-0654181.0001T34067AB01274800-01AB01274800_02EN300-27067685F863694Q414351BRD-A84575140-001-02-4Pimobendan, United States Pharmacopeia (USP) Reference Standard4,5-dihydro-6-[2-(4-methoxy-phenyl)-1h-benzimidazol-5-yl]-5-methyl-3 (2h)-pyridazinone4,5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl-3(2H)-pyridazinone6-[2-(4-Methoxyphenyl)-3H-benzimidazol-5-yl]-5-methyl-4,5-dihydro-2H-pyridazin-3-onePimobendan for system suitability, European Pharmacopoeia (EP) Reference Standard(+/-)-4,5-DIHYDRO-6-(2-(P-METHOXYPHENYL)-5-BENZIMIDAZOLYL)-5-METHYL-3(2H)-PYRIDAZINONE(5RS)-6-[2-(4-Methoxyphenyl)-1H-benzimidazol-5-yl]-5- methyl-4,5-dihydropyridazin-3(2H)-one3(2H)-PYRIDAZINONE, 4,5-DIHYDRO-6-(2-(4-METHOXYPHENYL)-1H-BENZIMIDAZOL-5-YL)-5-METHYL-, (+/-)-3(2H)-PYRIDAZINONE, 4,5-DIHYDRO-6-(2-(4-METHOXYPHENYL)-1H-BENZIMIDAZOL-6-YL)-5-METHYL-6-[2-(4-Methoxyphenyl)-1H-1,3-benzimidazol-6-yl]-5-methyl-4,5-dihydropyridazin-3(2H)-one6-[2-(4-methoxyphenyl)-1H-1,3-benzodiazol-6-yl]-5-methyl-2,3,4,5-tetrahydropyridazin-3-one
